[1]
|
Kew, M.C. (2014) Hepatocellular Carcinoma: Epidemiology and Risk Factors. Journal of Hepatocellular Carcinoma, 1, 115-125. https://doi.org/10.2147/JHC.S44381
|
[2]
|
McGlynn, K., Petrick, J.L. and El-Serag, H.B. (2021) Epidemiology of Hepatocellular Carcinoma. Hepatology, 73, 4-13. https://doi.org/10.1002/hep.31288
|
[3]
|
Chen, W., Zheng, R., Zhang, S., et al. (2017) Cancer Incidence and Mortality in China, 2013. Cancer Letters, 401, 63-71. https://doi.org/10.1186/s40880-017-0234-3
|
[4]
|
Ferlay, J., Shin, H., Bray, F., et al. (2010) Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917. https://doi.org/10.1002/ijc.25516
|
[5]
|
Jemal, A., Bray, F., Center, M.M., et al. (2011) Global Cancer Statistics. Carcinogenesis, 61, 69-90.
https://doi.org/10.3322/caac.20107
|
[6]
|
Xia, F., Wu, L., Lau, W.Y., et al. (2014) Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis. PLoS ONE, 9, e95889.
https://doi.org/10.1371/journal.pone.0095889
|
[7]
|
Jo, S. and Shim, H.K. (2013) A Patient Who Has Survived for a Long Period with Repeated Radiotherapies for Multifocal Extrahepatic Metastases from Hepatocellular Carcinoma. Radiation Oncology, 31, 267-272.
https://doi.org/10.3857/roj.2013.31.4.267
|
[8]
|
Natsuizaka, M., Omura, T., Akaike, T., et al. (2005) Clinical Features of Hepatocellular Carcinoma with Extrahepatic Metastases. Journal of Gastroenterology and Hepatology, 20, 1781-1787.
https://doi.org/10.1111/j.1440-1746.2005.03919.x
|
[9]
|
杨杰, 曹毅, 江艺, 等. CD44, CD90的表达与肝癌肝移植术后复发转移的关系[J]. 现代肿瘤医学, 2017, 25(19): 3089-3094.
|
[10]
|
Uka, K., Aikata, H., Takaki, S., et al. (2007) Clinical Features and Prognosis of Patients with Extrahepatic Metastases from Hepatocellular Carcinoma. World Journal of Gastroenterology, 13, 414-420.
https://doi.org/10.3748/wjg.v13.i3.414
|
[11]
|
Uchino, K., Tateishi, R., Shiina, S., et al. (2011) Hepatocellular Carcinoma with Extrahepatic Metastasis: Clinical Features and Prognostic Factors. Cancer, 117, 4475-4483. https://doi.org/10.1002/cncr.25960
|
[12]
|
张晓敏, 余吉仙. 首诊乙肝相关原发性肝癌肝外转移危险因素分析[J]. 浙江医学, 2019, 41(22): 2413-2416.
|
[13]
|
李果, 吴黎雳, 宦宏波, 等. 肝细胞癌肝外转移对患者生存预后的影响[J]. 中华解剖与临床杂志, 2014, 19(4): 307-309.
|
[14]
|
陈国彬, 黄星, 张真真. 基于SEER数据库的肝细胞肝癌脑转移危险因素分析[J]. 中外医学研究, 2020, 18(13): 12-15.
|
[15]
|
Carr, B.I. and Guerra, V. (2016) Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels. Oncology, 90, 136-142. https://doi.org/10.1159/000443480
|
[16]
|
Aino, H., Sumie, S., Niizeki, T., et al. (2014) Clinical Characteristics and Prognostic Factors for Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis. Molecular and Clinical Oncology, 2, 393-398.
https://doi.org/10.3892/mco.2014.259
|
[17]
|
Kanda, M., Tateishi, R., Yoshida, H., et al. (2008) Extrahepatic Metastasis of Hepatocellular Carcinoma: Incidence and Risk Factors. Liver International, 28, 1256-1263. https://doi.org/10.1111/j.1478-3231.2008.01864.x
|
[18]
|
Barr, D.C. and Hussain, H.K. (2014) MR Imaging in Cirrhosis and Hepatocellular Carcinoma. Magnetic Resonance Imaging Clinics of North America, 22, 315-335. https://doi.org/10.1016/j.mric.2014.04.006
|
[19]
|
Fukumoto, T., Kido, M., Takebe, A., et al. (2017) New Macroscopic Classification and Back-Flow Thrombectomy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Invading the Contralateral Second Portal Branch. Surgery Today, 47, 1094-1103. https://doi.org/10.1007/s00595-017-1507-9
|
[20]
|
Zhu, K., Chen, J., Lai, L., et al. (2014) Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study. Radiology, 272, 284-293. https://doi.org/10.1148/radiol.14131946
|
[21]
|
Mittal, S. and El-Serag, H.B. (2013) Epidemiology of Hepatocellular Carcinoma: Consider the Population. Journal of Clinical Gastroenterology, 47, S2-S6. https://doi.org/10.1097/MCG.0b013e3182872f29
|
[22]
|
Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. The Lancet, 362, 1907-1917.
|
[23]
|
刘通, 王万超, 陈思吟, 等. 丙氨酸氨基转移酶水平对原发性肝癌发病风险的预测价值(附95780例报告) [J]. 中华消化外科杂志, 2020, 19(12): 1257-1265.
|
[24]
|
Crasta, J.A., Premlatha, T., Krishnan, S.M., et al. (2010) Significance of Preoperative Thrombocytosis in Epithelial Ovarian Cancer. Indian Journal of Pathology and Microbiology, 53, 54. https://doi.org/10.4103/0377-4929.59184
|
[25]
|
陈俊宇, 邱俊, 吴珊, 等. 血小板及其受体促进卵巢癌转移的研究进展[J]. 中国实验诊断学, 2019, 23(7): 1272-1274.
|
[26]
|
Li, M.-M., Yue, C.-X., Fu, S., et al. (2019) Platelet Volume Is Reduced in Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts. Cancer Management and Research, 11, 9067-9072. https://doi.org/10.2147/CMAR.S221976
|
[27]
|
Li, L., Huang, X.-Y., Li, N., et al. (2019) Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases. Gastroenterology Research and Practice, 2019, Article ID: 6397513. https://doi.org/10.1155/2019/6397513
|
[28]
|
毛凯, 王捷. 肝癌合并肝外转移的外科治疗现状[J]. 中华外科杂志, 2019, 57(6): 466-470.
|
[29]
|
Kobayashi, S., Takahashi, S., Kato, Y., et al. (2011) Surgical Treatment of Lymph Node Metastases from Hepatocellular Carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 18, 559-566.
https://doi.org/10.1007/s00534-011-0372-y
|
[30]
|
Berger, Y., Spivack, J.H., Heskel, M., Aycart, S.N., Labow, D.M. and Sarpel, U. (2017) Extrahepatic Metastasectomy for Hepatocellular Carcinoma: Predictors of Long-Term Survival. Journal of Surgical Oncology, 115, 505-506.
https://doi.org/10.1002/jso.24555
|
[31]
|
王磊, 咸玉涛, 杨正强, 施海彬. 不同治疗方案对晚期肝细胞性肝癌预后的影响及因素分析[J]. 中华介入放射学电子杂志, 2018, 6(2): 104-108.
|
[32]
|
Lee, C.W., Chan, K.M., Lee, C.F., et al. (2011) Hepatic Resection for Hepatocellular Carcinoma with Lymph Node Metastasis: Clinicopathological Analysis and Survival Outcome. Asian Journal of Surgery, 34, 53-62.
https://doi.org/10.1016/S1015-9584(11)60020-1
|
[33]
|
叶胜龙. 重视中晚期肝癌的降期转化治疗[J]. 临床肝胆病杂志, 2020, 36(2): 249-251.
|
[34]
|
耿小平, 周俭, 王征, 等. 肝脏恶性肿瘤合并肝外转移的外科治疗[J]. 中华消化外科杂志, 2019(4): 328-335.
|
[35]
|
刘少儒, 许磊波. 肝癌肝移植术后复发转移的免疫治疗[J]. 器官移植, 2021, 12(3): 272-279.
|
[36]
|
伍慧丽, 郑素军, 段钟平. 从解剖学角度探讨原发性肝癌的转移途径[J]. 临床肝胆病杂志, 2017, 33(10): 2009-2015.
|
[37]
|
秦建民. 转移性肝癌个体化治疗方案的选择与临床意义[J]. 世界华人消化杂志, 2018, 26(29): 1677-1687.
|